- Stocks
- Healthcare
BLCO
Bausch + Lomb Corporation
BLCO
NYSE·Healthcare·Medical - Instruments & Supplies·Mkt cap $6.4B
$18.04
▼ -0.55%
P/E
-37.66
Mkt Cap
$6.4B
52-Wk Range
$13.77–$18.92
52-Week Range
$13.77 - $18.92
P/E
Fwd P/E
Beta
Div Yield
Avg Vol
Shares Out
Mkt Cap
Price action
Price chart
Up 16.2% over the trailing year
Total returns
Price performance
Total return across standard periods - splits & dividends adjusted by FMP. Periods longer than 1Y show annualized in the tooltip.
Why we rate it this way
The thesis at a glance
Bull and bear case · plain-English context across the five lenses we evaluate.
Bull Case
4 reasons
- 170+ year heritage and brand recognition in eye health
- Diversified product portfolio across three complementary segments
- Extensive global distribution network and market penetration
- Proprietary pharmaceutical formulations and surgical technology
Bear Case
2 risks
- Low volatility (beta 0.6).
- Premium valuation to Medical Devices peers
Growth
Turning profitable
Aging global population increasing demand for eye care treatments
Value
Premium valuation to Medical Devices peers
Momentum
Strong
+18.8% over 3m
Quality
Strong
Excellent business quality
Dividend
None
No dividend
Smart-money signal
Who's buying BLCO right now
Insider Form 4s, 13F institutional filings, and Congressional disclosures - at a glance.
Earnings track record
Latest print - beat on both lines
AI-summarized recap of last quarter, plus the surprise on every print.
Next: Nov 4, 2026
JUL 29, 2026
Reported EPS of $0.16 vs $0.15 consensus (+3.6% surprise). Revenue of $1.4B vs $1.4B expected (+1.8%). Beat on both top and bottom lines.
EPS surprise · last 4Q
1 of 1 beats
Estimate
Actual
Q3 26
+3.6%
Revenue trend · last 8Q
—
—
—
+5%
+7%
+10%
+9%
+9%
Q3 24
Q4 24
Q1 25
Q2 25
Q3 25
Q4 25
Q1 26
Q2 26
$1.2B
$1.3B
$1.1B
$1.3B
$1.3B
$1.4B
$1.2B
$1.4B
Margins · last 8Q
Gross
56.5%
Operating
6.0%
Profit
-1.0%
Wall Street consensus
4 analysts · 75% Buy
Live ratings and price targets aggregated across covering analysts.
Buy
75%
Hold
25%
Sell
0%
Median Price Target
—
Latest: HC Wainwright · Aug 28, 2026
vs Industry
How BLCO stacks vs Medical - Instruments & Supplies
Stock metrics vs industry averages. Green = better than industry.
Industry comparison data unavailable for this stock.
Related